Centene Corp. (CNC)
NYSE • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Centene Corp. keeps $2 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 27
in 23 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Centene’s revenue fell 9% to about $44.4 billion in the second fiscal quarter of 2026, reported July 28, from about $48.7 billion a year earlier, while gross profit reached roughly $4.6 billion and gross margin held near 10%. Operating cash flow was $4.36 billion, and the company repurchased $4.0 million of stock. Consensus for the next period calls for EPS of $0.07.
Next report — what to expect
Centene Corp. (CNC) is scheduled to report on October 27, 2026. Wall Street is looking for EPS of $0.07 on revenue of $47.11 billion. For trailing context, revenue fell -9.0% year over year last quarter. Centene has beaten EPS in 7 of its 8 most recent quarters.
About Centene Corp.
Centene Corp. is a managed-care company on the NYSE under the ticker CNC that focuses on government-sponsored and commercial health coverage in the United States. Across its health plan and care-delivery operations, it generated $194.8 billion of revenue in FY2025.
Today's Snapshot
CNC closed 3.3% above yesterday's close, while its sector was flat. Volume was about two-thirds of its usual level. Centene is cutting Medicare Advantage plans in less profitable markets.
Trading Volume
Below 10d avg (4.3M)
2.6M
vs S&P 500 Today
Outperforming Market
+2.49%
Updated: October 2, 2026 at 20:10 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$53.35 - $64.07Buy
- RSI (14)46.15Neutral
- Stochastic %K (14, 3, 3)21.37Neutral
- MACD Level (12, 26)-0.97Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.